Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Mollenhauer

Showing results (21-30 of 80) with videos related to

Pageof 8
Sort By:
SLAS Discovery : Advancing Life Sciences R & D|October 13, 2016
Efficient Management of High-Throughput Screening Libraries with SAVANAHMarkus List, Marlene Pedersen Elnegaard, Steffen Schmidt, et al.
Journal of Clinical Biochemistry and Nutrition|November 20, 2013
Dmbt1 does not affect a Western style diet-induced liver damage in miceAstrid Reichold, Sibylle A Brenner, Karin Förster-Fromme, et al.
Journal of Integrative Bioinformatics|June 24, 2014
Classification of breast cancer subtypes by combining gene expression and DNA methylation dataMarkus List, Anne-Christin Hauschild, Qihua Tan, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|April 27, 2010
David versus GoliathJan Mollenhauer, Dimitrios Stamou, Allan Flyvbjerg, et al.
Chemical Communications (Cambridge, England)|September 11, 2010
The pattern recognition molecule deleted in malignant brain tumors 1 (DMBT1) and synthetic mimics inhibit liposomal nucleic acid deliveryPernille Lund Hansen, Stephanie Blaich, Caroline End, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 31, 2014
Evaluation of cobalt-labeled octreotide analogs for molecular imaging and auger electron-based radionuclide therapyHelge Thisgaard, Birgitte Brinkmann Olsen, Johan Hygum Dam, et al.
Cancer Letters|August 30, 2008
Genetic variation of Aflatoxin B1 aldehyde reductase genes (AFAR) in human tumour cellsChristian Praml, Wolfgang Schulz, Andreas Claas, et al.
Plos One|May 22, 2013
A variant form of the human deleted in malignant brain tumor 1 (DMBT1) gene shows increased expression in inflammatory bowel diseases and interacts with dimeric trefoil factor 3 (TFF3)Jens Madsen, Grith Lykke Sorensen, Ole Nielsen, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|December 11, 2012
Cardiac amyloidosis induces up-regulation of Deleted in Malignant Brain Tumors 1 (DMBT1)Hanna Müller, Marcus Renner, Frank Bergmann, et al.
European Journal of Cancer (Oxford, England : 1990)|January 16, 2007
Allelic variants of CAMTA1 and FLJ10737 within a commonly deleted region at 1p36 in neuroblastomaKai-Oliver Henrich, Andreas Claas, Christian Praml, et al.
Pageof 8

Showing results (21-30 of 80) with videos related to

Sort By:
Pageof 8
SLAS Discovery : Advancing Life Sciences R & D|October 13, 2016
Efficient Management of High-Throughput Screening Libraries with SAVANAHMarkus List, Marlene Pedersen Elnegaard, Steffen Schmidt, et al.
Journal of Clinical Biochemistry and Nutrition|November 20, 2013
Dmbt1 does not affect a Western style diet-induced liver damage in miceAstrid Reichold, Sibylle A Brenner, Karin Förster-Fromme, et al.
Journal of Integrative Bioinformatics|June 24, 2014
Classification of breast cancer subtypes by combining gene expression and DNA methylation dataMarkus List, Anne-Christin Hauschild, Qihua Tan, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|April 27, 2010
David versus GoliathJan Mollenhauer, Dimitrios Stamou, Allan Flyvbjerg, et al.
Chemical Communications (Cambridge, England)|September 11, 2010
The pattern recognition molecule deleted in malignant brain tumors 1 (DMBT1) and synthetic mimics inhibit liposomal nucleic acid deliveryPernille Lund Hansen, Stephanie Blaich, Caroline End, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 31, 2014
Evaluation of cobalt-labeled octreotide analogs for molecular imaging and auger electron-based radionuclide therapyHelge Thisgaard, Birgitte Brinkmann Olsen, Johan Hygum Dam, et al.
Cancer Letters|August 30, 2008
Genetic variation of Aflatoxin B1 aldehyde reductase genes (AFAR) in human tumour cellsChristian Praml, Wolfgang Schulz, Andreas Claas, et al.
Plos One|May 22, 2013
A variant form of the human deleted in malignant brain tumor 1 (DMBT1) gene shows increased expression in inflammatory bowel diseases and interacts with dimeric trefoil factor 3 (TFF3)Jens Madsen, Grith Lykke Sorensen, Ole Nielsen, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|December 11, 2012
Cardiac amyloidosis induces up-regulation of Deleted in Malignant Brain Tumors 1 (DMBT1)Hanna Müller, Marcus Renner, Frank Bergmann, et al.
European Journal of Cancer (Oxford, England : 1990)|January 16, 2007
Allelic variants of CAMTA1 and FLJ10737 within a commonly deleted region at 1p36 in neuroblastomaKai-Oliver Henrich, Andreas Claas, Christian Praml, et al.
Pageof 8